Robert H. Weiss,Bruce D. Hammock,Hiromi Inoue,Sung Hee Hwang
申请号：
US14408280
公开号：
US20150132408A1
申请日:
2013.06.20
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention provides sorafenib analogs for use in a method of treating a disease mediated by p21, said method comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula I. The present invention also provides methods of inhibiting p21 in a cell comprising contacting the cell with an effective amount of a compound of formula I.
